Summary:
«After taking part in proving the clinical benefit of using AI-based decision support tools, as was recently published in Nature Medicine, Yale New Haven Health System and DreaMed Diabetes announced a collaboration that will explore what it would take to adopt such a solution into a real-world health system.»
Article written by Fred Pennic
15|03|2021
Source:
HIT Consultant